by Mike and Colin | Feb 24, 2022 | Company Analysis, Earnings Report
Weedmaps reported 4Q21 earnings (presentation) and updated guidance for 2022; revenue beat the reduced expectations of 3Q21, revenue guidance for 2022 was reiterated, while profitability guidance was significantly lower than expected as the company increases...
by Mike and Colin | Feb 7, 2022 | Weekly Extract
Welcome to the Weekly Extract, parsing key information out of the week’s cannabis headlines. This week’s Extract covers …. Recently Published: MJResearchCo presentation on SPACs from Fall 2021 Cannabis trades at valuations where consumer companies...
by Mike and Colin | Nov 19, 2021 | Weekly Extract
Welcome to the Weekly Extract, parsing key information out of the week’s cannabis headlines. This week’s Extract covers 3Q21 earnings reviews of Hyrdofarm, GrowGen, Agrify, Urban-Gro, Columbia Care, Trulieve, Verano, and Jushi, Eaze, and also looks at Rx...
by Mike and Colin | Nov 18, 2021 | Company Analysis, Data & Analysis, In the News, M&A / Capital Raise, Macro
On October 19, 2019, Mike Regan presented on SPACs (Special Purpose Acquisition Corps) at the MJBizCon Finance Forum. The presentation walked through: Key risks to investing in SPACs How to invest across the SPAC lifecycle process The players and incentives during the...
by Mike and Colin | Nov 16, 2021 | Company Analysis, Earnings Report
MAPS guided significantly below prior guidance for 4Q21 and 2022, blaming softness on a demand shift to the illicit market and slower than expected license issuances. Our more detailed review and updated model for Premium Members can be found below. While the...
